Cargando…
β(2)-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam Study
The role of the β(2)-adrenergic receptor (ADRB2) gene in patients with chronic obstructive pulmonary disease (COPD) is unclear. We investigated the association between ADRB2 variants and the risk of exacerbations in COPD patients treated with inhaled β(2)-agonists. Within the Rotterdam Study, a popu...
Autores principales: | Karimi, Leila, Lahousse, Lies, Ghanbari, Mohsen, Terzikhan, Natalie, Uitterlinden, André G., van der Lei, Johan, Brusselle, Guy G., Stricker, Bruno H., Verhamme, Katia M. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912270/ https://www.ncbi.nlm.nih.gov/pubmed/31683975 http://dx.doi.org/10.3390/jcm8111835 |
Ejemplares similares
-
Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study
por: Karimi, Leila, et al.
Publicado: (2021) -
Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016) -
Incidence and predictors of asthma exacerbations in middle-aged and older adults: the Rotterdam Study
por: de Roos, Emmely W., et al.
Publicado: (2021) -
COPD is associated with an increased risk of peripheral artery disease and mortality
por: Terzikhan, Natalie, et al.
Publicado: (2018) -
Sarcopenia in older people with chronic airway diseases: the Rotterdam study
por: Benz, Elizabeth, et al.
Publicado: (2021)